Pfizer Inc.
Therapeutic nanoparticles comprising a protonatable nitrogen therapeutic agent and methods of making and using same
Last updated:
Abstract:
The present disclosure generally relates to nanoparticles comprising a substantially hydrophobic acid, a basic therapeutic agent having a protonatable nitrogen, and a polymer. Other aspects include methods of making and using such nanoparticles.
Status:
Grant
Type:
Utility
Filling date:
7 Sep 2018
Issue date:
10 Mar 2020